Playtex Q2 charge
This article was originally published in The Rose Sheet
Executive SummaryConsumer products company will take $3.8 mil. after-tax charge in the second quarter related to amendment of its credit agreement, firm states. Playtex issued new $450 mil. loan, and with $21.8 mil. cash, used it to repay existing $76 mil. and $395.8 mil. loans, company says. As a result, Playtex expects to realize interest savings of approximately $3.1 mil. over the next year, firm explains...
You may also be interested in...
Hikma and Civica Rx have announced the launch of a first wave of eight essential injectable medicines, including heparin, as part of a deal struck between the two firms earlier this year.
A PFS benefit and favorable tolerability profile associated with AstraZeneca’s BTK inhibitor acalabrutinib used first-line in CLL, when given alone or combined with obinutuzumab, may serve it well against entrenched competitors and BTK inhibitors in clinical development.
Amneal has acquired a majority stake in manufacturer and wholesaler AvKARE, giving the firm access to the “large, complex and growing federal healthcare market.”